Automating Success: Ensuring Annex-1 Compliance in Final Filtration
WEBINAR
In this webinar, you will learn:
- How Annex-1 requirements impact Final Filtration operations, focusing on PUPSIT implementation
- Why single-use assemblies can reduce patient and business risks
- How an automated system can optimize product recovery and your facility layout
Final sterilizing filtration is the critical last step in ensuring the sterility of medicinal products for human use. As single-use platforms gain traction in bioprocessing, a comprehensive approach is essential to guarantee the sterility of the entire system, including filters and components. With EU GMP Annex-1 mandating integrity tests on sterilized filter assemblies both before and after use, the complexity of manual operations increases, necessitating careful evaluation.
This is your opportunity to discover how our innovative solutions empower biomanufacturers to meet stringent regulatory requirements while enhancing their contamination control strategies.
Speaker List

Mehdi Boukami
Merck
Field Marketing Specialist - Single-Use Technologies
Mehdi Boukami holds a Master’s degree in Biomolecular Engineering from the Bordeaux National School of Biomolecule Technology. He joined Merck in 2008 and held multiple customer-facing positions involving filtration & single use business. In his role, he investigates the market needs and trends of single-use technologies with a focus on critical application such as final filtration & filling, and other key topics such as quality requirements and supply.

Ivy Chiu (Moderator)
Merck
Customer Application Expert - Single-Use & Integrated Platform Solutions
Ivy Chiu, Technology and Application Expert of Single-Use technologies and Integrated Systems for Merck, Process Solutions division, she strives to provide technical expertise and knowledge of the products, applications, process, market and worked with the end users to delivered solutions and technical training in pharmaceutical companies, industrial associations, institutes and government linked bodies.
Pharma and biopharma manufacturing
- Monoclonal antibody manufacturing
期间:1h
语言:English
场次 1:Tue, April 14, 2026 2:00 PM SGT
如要继续阅读,请登录或创建帐户。
暂无帐户?